Nasal septal perforation in systemic lupus erythematosus.
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D004844:Epistaxis / Q000209:etiology; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007070:Immunoglobulin A / Q000032:analysis; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy; D008297:Male; D009300:Nasal Septum / Q000276:immunology; D009668:Nose Diseases / Q000150:complications / Q000209:etiology; D009824:Ointments; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence
D007070:Immunoglobulin A; D009824:Ointments; D006886:Hydroxychloroquine; D011241:Prednisone